ASTS
AST SpaceMobile, Inc.
ASTS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BHE
Benchmark Electronics, Inc.
BHE has the edge over ASTS overall, supported by lower modeled downside and stronger modeled upside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BHE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
BHE's revenue, profitability, cash flow and balance sheet are all currently healthy.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
BHE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $25.39 | -61% |
| Forward | 19x | $64.81 | — |
| Fair | 26x | $40.74 | -37% |
| Current | 42x | $64.81 | — |
| Expensive | 61x | $93.51 | +44% |
Historical ranges are pointers, not guarantees.
BHE's PE is in its expensive range at 42x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BHE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BHE, with profitability holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
BHE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.41 | +121% |
| Q3 2026 | $1.54 | +52% |
| Q2 2026 | $1.46 | +40% |
| Q1 2026 | $0.94 | -35% |
| Q4 2025 | $0.68 | -60% |
| Q3 2025 | $1.01 | -41% |
| Q2 2025 | $1.04 | -44% |
| Q1 2025 | $1.44 | -21% |
| Q4 2024 | $1.72 | -3.9% |
BHE has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over BHE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
BHE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $810.9M | +19% |
| Q2 2026 | $756M | +18% |
| Q1 2026 | $677.3M | +7.2% |
| Q4 2025 | $704.3M | +7.2% |
| Q3 2025 | $680.7M | +3.5% |
| Q2 2025 | $642.3M | -3.5% |
| Q1 2025 | $631.8M | -6.5% |
| Q4 2024 | $656.9M | -5% |
BHE's revenue has grown year over year for five quarters in a row: $811M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.8% | +0.3 points |
| Q2 2026 | 4% | +0.8 points |
| Q1 2026 | 3.2% | +1.4 points |
| Q4 2025 | 2.9% | -1.5 points |
| Q3 2025 | 3.5% | -0.8 points |
| Q2 2025 | 3.2% | -0.9 points |
| Q1 2025 | 1.9% | -1.9 points |
| Q4 2024 | 4.3% | -0.3 points |
BHE has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
BHE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $15.4M | -39% |
| Q2 2026 | $21.8M | +$36.9M |
| Q1 2026 | $31M | +10% |
| Q4 2025 | $48.2M | +30% |
| Q3 2025 | $25.1M | -14% |
| Q1 2025 | $28.1M | -35% |
| Q4 2024 | $37.2M | -71% |
| Q3 2024 | $29.2M | +63% |
BHE has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
BHE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -1K shares |
| 1 year | +0.6% | +214K shares |
| 3 years | +1.4% | +520K shares |
| 5 years | +2% | +730K shares |
| Available history | -6.1% | -2.4M shares |
BHE has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8.5M |
| Q2 2026 | — |
| Q1 2026 | $5.8M |
| Q4 2025 | $854,000 |
| Q3 2025 | $10M |
| Q2 2025 | $8M |
| Q1 2025 | $8M |
| Q4 2024 | $1,000 |
BHE spent $15M buying back its own shares over the past year, down 42% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BHE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
BHE has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
BHE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.6 | Neutral |
| Stochastic | 14.1 | Oversold |
BHE's weekly RSI is 43 (neutral) and its Stochastic is 14 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
BHE PE vs Technology Sector
| Metric | BHE | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 28x | 51% above |
| PE % | 69 | 35 | 34 pts above |
BHE is trading at 42x earnings, a 51% premium to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
BHE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.7 | 11% below |
| 20 week MA | $76.3 | 15% below |
| 50 week MA | $68.7 | 5.7% below |
| 100 week MA | $54.4 | 19% above |
| 200 week MA | $43.0 | 51% above |
BHE has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
BHE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.6 | $26.7 | -23% |
| 2021 | $26.7 | $26.4 | -1% |
| 2022 | $26.4 | $27.0 | +2.2% |
| 2023 | $27.0 | $27.6 | +2.4% |
| 2024 | $27.6 | $46.1 | +67% |
| 2025 | $46.1 | $44.8 | -2.8% |
| 2026 YTD | $44.8 | $64.8 | +45% |
BHE has the edge over ASTS on returns for 2026, with the stronger performance.